MAJI (Exousia Pro) Days Inventory: 0.00 (As of Jan. 2021)


What is Exousia Pro Days Inventory?

Exousia Pro MAJI -1.92% Days Inventory is 0.00 as of Jan. 2021.

Days Inventory is also known as Days Sales of Inventory (DSI). Exousia Pro's Average Total Inventories for the three months ended in Jan. 2021 was $0.00 Mil. Exousia Pro's Cost of Goods Sold for the three months ended in Jan. 2021 was $0.00 Mil.

The historical rank and industry rank for Exousia Pro's Days Inventory or its related term are showing as below:

MAJI's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.37
* Ranked among companies with meaningful Days Inventory only.

Exousia Pro's Days Inventory stayed the same from Jan. 2020 (0.00) to Jan. 2021 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Exousia Pro  (OTCPK:MAJI) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Exousia Pro's Inventory Turnover for the three months ended in Jan. 2021 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Exousia Pro's Inventory to Revenue for the three months ended in Jan. 2021 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Exousia Pro Days Inventory Related Terms


Exousia Pro Days Inventory Historical Data

* Premium members only.

The historical data trend for Exousia Pro's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Exousia Pro Days Inventory Chart

Exousia Pro Annual Data
Trend Apr11 Apr12 Apr18 Apr19
Days Inventory
0.00 0.00 0.00 0.00

Exousia Pro Quarterly Data
Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MAJI vs HCCH, GRNV, AGBA: Days Inventory Comparison

For the Biotechnology subindustry, Exousia Pro's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Exousia Pro Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exousia Pro's Days Inventory distribution charts can be found below:

* The bar in red indicates where Exousia Pro's Days Inventory falls into.



Exousia Pro Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Exousia Pro's Days Inventory for the fiscal year that ended in Apr. 2019 is calculated as

Days Inventory (A: Apr. 2019 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Apr. 2018 ) + Total Inventories (A: Apr. 2019 )) / count ) / Cost of Goods Sold (A: Apr. 2019 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Exousia Pro's Days Inventory for the quarter that ended in Jan. 2021 is calculated as:

Days Inventory (Q: Jan. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Oct. 2020 ) + Total Inventories (Q: Jan. 2021 )) / count ) / Cost of Goods Sold (Q: Jan. 2021 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 4
=0 / 0*365 / 4
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Exousia Pro (MAJI) has a Days Inventory of 0.00 as of Jan. 2021. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Exousia Pro and its competitors.
Is Exousia Pro's Days Inventory too high?
Exousia Pro's current Days Inventory is 0.00.
How does Exousia Pro's Days Inventory compare to HCCH and GRNV?
Exousia Pro's Days Inventory of 0.00 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.37. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.37, based on 637 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Exousia Pro and its competitors. For the Biotechnology industry, the median Days Inventory is 183.37 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Exousia Pro's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Exousia Pro stock overvalued right now?
Exousia Pro (MAJI) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Exousia Pro (MAJI), the current Days Inventory is 0.00 as of Jan. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Exousia Pro Business Description

Address 7901 4th Street North, No. 23494, St. Petersburg, FL, USA, 33702
Exousia Pro Inc is a exosome-based biotechnology, develops and manufactures mammalian and plant-based exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company is developing new ways to exploit the therapeutic potential of exosomes, initially focused in the field of oncology. The platform technology of the company also helps treating a broad spectrum of viral infections.